Get started
Author

Medea Gegia

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
2018 · Nafees Ahmad, Shama D Ahuja, et al. · The Lancet · 633
World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update
2020 · Fuad Mirzayev, Kerri Viney, et al. · European Respiratory Journal · 299
PDF
Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis
2016 · Medea Gegia, Nicholas Winters, et al. · The Lancet Infectious Diseases · 276
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis
2018 · Elizabeth P. Harausz, Anthony J. Garcia-Prats, et al. · PLoS Medicine · 151
PDF
World Health Organization treatment outcome definitions for tuberculosis: 2021 update
2021 · Nguyen Nhat Linh, Kerri Viney, et al. · European Respiratory Journal · 141
PDF
Point of care diagnostics for tuberculosis
2018 · A.L. García-Basteiro, A. DiNardo, et al. · Pulmonology · 131
PDF
Mycobacterium tuberculosis Beijing Lineage Favors the Spread of Multidrug-Resistant Tuberculosis in the Republic of Georgia
2010 · Stefan Niemann, Roland Diel, et al. · Journal of Clinical Microbiology · 115
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis
2018 · Federica Fregonese, Shama D Ahuja, et al. · The Lancet Respiratory Medicine · 110
PDF
New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization
2021 · Kerri Viney, Nguyen Nhat Linh, et al. · European Respiratory Journal · 83
Tobacco smoking and tuberculosis treatment outcomes: a prospective cohort study in Georgia
2015 · Medea Gegia, Matthew J Magee, et al. · Bulletin of the World Health Organization · 67
PDF
Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007–2009
2012 · M. Gegia, T. Cohen, et al. · The International Journal of Tuberculosis and Lung Disease · 51
Monitoring Therapeutic Efficacy by Real-Time Detection of Mycobacterium tuberculosis mRNA in Sputum
2009 · Nino Mdivani, Haijing Li, et al. · Clinical Chemistry · 51
Adjunctive surgery improves treatment outcomes among patients with multidrug-resistant and extensively drug-resistant tuberculosis
2012 · Medea Gegia, Iagor Kalandadze, et al. · International Journal of Infectious Diseases · 48
The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis
2023 · Tasnim Hasan, Ellie Medcalf, et al. · Clinical Infectious Diseases · 42
PDF
Prevalence of and Molecular Basis for Tuberculosis Drug Resistance in the Republic of Georgia: Validation of a QIAplex System for Detection of Drug Resistance-Related Mutations
2007 · Medea Gegia, Nino Mdivani, et al. · Antimicrobial Agents and Chemotherapy · 40
Situational analysis of 10 countries with a high burden of drug-resistant tuberculosis 2 years post-UNHLM declaration: progress and setbacks in a changing landscape
2021 · Ignacio Monedero-Recuero, Medea Gegia, et al. · International Journal of Infectious Diseases · 27
PDF
Outcomes of children treated for tuberculosis with second-line medications in Georgia, 2009–2011
2013 · M. Gegia, H. E. Jenkins, et al. · The International Journal of Tuberculosis and Lung Disease · 27
Target regimen profiles for tuberculosis treatment
2024 · Christian Lienhardt, Kelly Dooley, et al. · Bulletin of the World Health Organization · 26
Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis
2019 · Muhammad Osman, Elizabeth P. Harausz, et al. · Emerging infectious diseases · 24
PDF
Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience
2011 · Jennifer Furin, Medea Gegia, et al. · Bulletin of the World Health Organization · 24
PDF
Geographical heterogeneity of multidrug-resistant tuberculosis in Georgia, January 2009 to June 2011
2014 · H E Jenkins, M Gegia, et al. · Eurosurveillance · 20
PDF
High Utility of Contact Investigation for Latent and Active Tuberculosis Case Detection among the Contacts: A Retrospective Cohort Study in Tbilisi, Georgia, 2010–2011
2014 · Tsira Chakhaia, Matthew J. Magee, et al. · PLoS ONE · 17
PDF
Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis
2025 · Anthony J Garcia-Prats, Maria Garcia-Cremades, et al. · The Lancet Child & Adolescent Health · 14
PDF
Treatment of Multidrug-resistant or Rifampicin-resistant Tuberculosis With an All-oral 9-month Regimen Containing Linezolid or Ethionamide in South Africa: A Retrospective Cohort Study
2024 · Hannah Morgan, Norbert Ndjeka, et al. · Clinical Infectious Diseases · 12
PDF
Changes in treatment for multidrug-resistant tuberculosis according to national income
2020 · Nakwon Kwak, Nicholas Winters, et al. · European Respiratory Journal · 9
PDF
Works count: 42
Citation count: 2,456
H-index: 20
I10-index: 24
Year
Topic
Type